Mesenchymal stem cells
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD of poor graft function: a multicenter phase II study.
- Principal investigator: Prof. Dr. Johan Maertens
- More information: NCT00603330
- Internal reference number: S50710
Rockforward (EFC22965)
A parallel group, Phase 3, randomized, open-label, 2-arm study to demonstrate the superiority of belumosudil versus best available therapy (BAT) in participants at least 12 years of age with chronic graft versus host disease (cGVHD) refractory to or recurrent after 2 to 5 prior lines of systemic therapy
- Principal investigator: Prof. Dr. Hélène Schoemans
- More information: NCT07771439
- Internal reference number: S72284
Vragen en contact
-
Via deze weg kunt u geen afspraak maken.